Nano Metallic-Oxides as Antimicrobials for Implant Coatings


Article Preview

The use of metallic nanoparticles in the field of orthopaedics as antimicrobial components of coatings is receiving particular attention. An innovative approach has been developed whereby various metal/metal oxide nanoparticles are used to prevent infection occurring on the surface of prostheses. In this study nano metallic oxides (zinc oxide - ZnO and tungsten oxide - WO3) were used. Minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) values of each nanoparticulate were determined against four species of bacteria (Staphylococcus aureus, Escherichia coli, Staphylococcus epidermidis and Pseudomonas aeruginosa). Subsequently the nanoparticles were prepared in a suspension of ethanol and sprayed onto the surface of glass using electrohydrodynamic deposition. Quantitative assessments as regards the antimicrobial properties of these coated samples were carried out. Comparisons of the antibacterial properties demonstrated that 2500 µg/ml or above of the oxides were required to kill the species of bacteria tested. WO3 was the most effective oxide tested in suspension using growth inhibition tests. However, coated samples demonstrated that ZnO was more bactericidal than WO3 under these conditions.



Key Engineering Materials (Volumes 493-494)

Main Theme:

Edited by:

Eyup Sabri Kayali, Gültekin Göller and Ipek Akin




K. Memarzadeh et al., "Nano Metallic-Oxides as Antimicrobials for Implant Coatings", Key Engineering Materials, Vols. 493-494, pp. 489-494, 2012

Online since:

October 2011




[1] Green, S.A., Complications of external skeletal fixation. Clin Orthop Relat Res, 1983(180): pp.109-16.

[2] Moroni, A., et al., State of the art review: techniques to avoid pin loosening and infection in external fixation. J Orthop Trauma, 2002. 16(3): pp.189-95.


[3] Soballe, K., et al., A review of ceramic coatings for implant fixation. J Long Term Eff Med Implants, 1999. 9(1-2): pp.131-51.

[4] Allaker, R.P., The use of nanoparticles to control oral biofilm formation. J Dent Res, 2010. 89(11): pp.1175-86.

[5] Rao, N., B.H. Ziran, and B.A. Lipsky, Treating osteomyelitis: antibiotics and surgery. Plast Reconstr Surg, 2011. 127 Suppl 1: p. 177S-187S.


[6] Andersson, D.I. and D. Hughes, Persistence of antibiotic resistance in bacterial populations. FEMS microbiology reviews, (2011).

[7] Yang, Z. and C. Xie, Zn2+ release from zinc and zinc oxide particles in simulated uterine solution. Colloids and surfaces. B, Biointerfaces, 2006. 47(2): pp.140-5.


[8] Pal, S., Y.K. Tak, and J.M. Song, Does the antibacterial activity of silver nanoparticles depend on the shape of the nanoparticle? A study of the Gram-negative bacterium Escherichia coli. Applied and environmental microbiology, 2007. 73(6): pp.1712-20.


[9] Colon, G., B.C. Ward, and T.J. Webster, Increased osteoblast and decreased Staphylococcus epidermidis functions on nanophase ZnO and TiO2. Journal of biomedical materials research. Part A, 2006. 78(3): pp.595-604.


[10] Premanathan, M., et al., Selective toxicity of ZnO nanoparticles toward Gram-positive bacteria and cancer cells by apoptosis through lipid peroxidation. Nanomedicine : nanotechnology, biology, and medicine, 2011. 7(2): pp.184-92.


[11] Nair, S., et al., Role of size scale of ZnO nanoparticles and microparticles on toxicity toward bacteria and osteoblast cancer cells. Journal of materials science. Materials in medicine, 2009. 20 Suppl 1: p. S235-41.


[12] Pujalte, I., et al., Cytotoxicity and oxidative stress induced by different metallic nanoparticles on human kidney cells. Particle and fibre toxicology, 2011. 8: p.10.


[13] Lai, J.C., et al., Exposure to titanium dioxide and other metallic oxide nanoparticles induces cytotoxicity on human neural cells and fibroblasts. International journal of nanomedicine, 2008. 3(4): pp.533-45.